Cargando…
Degree of obesity and gastrointestinal adverse reactions influence the weight loss effect of liraglutide in overweight or obese patients with type 2 diabetes
BACKGROUND: Liraglutide can effectively reduce the weight of patients with type 2 diabetes. Nonetheless, its weight loss effect was highly heterogeneous in different patients in the clinical practice. OBJECTIVE: To identify the factors most associated with the weight loss effect of liraglutide in ob...
Autores principales: | Zhou, Fang, Jiang, Lu, Guo, Jiamei, Fan, Yuting, Pan, Qin, Li, Tianlian, Sun, Xiaoshi, Li, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026133/ https://www.ncbi.nlm.nih.gov/pubmed/36950020 http://dx.doi.org/10.1177/20406223231161516 |
Ejemplares similares
-
Efficacy and Safety of Liraglutide and Semaglutide on Weight Loss in People with Obesity or Overweight: A Systematic Review
por: Xie, Zeyu, et al.
Publicado: (2022) -
Benefits of Liraglutide Treatment in Overweight and Obese Older Individuals With Prediabetes
por: Kim, Sun H., et al.
Publicado: (2013) -
Gastrointestinal tolerability of once‐weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss
por: Wharton, Sean, et al.
Publicado: (2021) -
Omentin as an Independent Predictor of Metabolic Syndrome and Obesity Among Adolescents in Northeast China
por: Sun, Xiaoshi, et al.
Publicado: (2022) -
Effect of semaglutide and liraglutide in individuals with obesity or
overweight without diabetes: a systematic review
por: Deng, You, et al.
Publicado: (2022)